ArticleACS omega2025
Optimized Degradation of Doxycycline in Aqueous Systems Using Calcium Peroxide Nanoparticles via Response Surface Methodology.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The presence of antibiotic residues in aqueous systems, particularly doxycycline (DOX), is harmful to the environment and public health. In this study, dextran-coated calcium peroxide nanoparticles (DEX@nCPs(DEX)), Fe(II), and oxalic acid (OA) were combined to improve the heterogeneous Fenton-like degradation of DOX. X-ray photoelectron spectroscopy (XPS) demonstrated the successful synthesis of DEX@nCPs(DEX), showing the presence of Ca, O, and C functional groups associated with dextran. Using response surface methodology with a central composite design (RSM-CCD), the optimal conditions (DEX@nCPs(DEX) dosage: 2 g/L, pH: 5, contact time: 420 min) achieved 90% DOX removal, which was 20% higher than using DEX@nCPs(DEX)/Fe(II) alone. The degradation process followed first-order kinetics with a rate constant of
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.